Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 325

Similar articles for PubMed (Select 11403509)

1.

Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia.

Davidson MH, Toth P, Weiss S, McKenney J, Hunninghake D, Isaacsohn J, Donovan JM, Burke SK.

Clin Cardiol. 2001 Jun;24(6):467-74.

PMID:
11403509
2.

Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.

Knapp HH, Schrott H, Ma P, Knopp R, Chin B, Gaziano JM, Donovan JM, Burke SK, Davidson MH.

Am J Med. 2001 Apr 1;110(5):352-60.

PMID:
11286949
3.

Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.

Bays HE, Davidson M, Jones MR, Abby SL.

Am J Cardiol. 2006 Apr 15;97(8):1198-205. Epub 2006 Mar 3. Erratum in: Am J Cardiol. 2006 Aug 1;98(3):428.

PMID:
16616026
4.

Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects.

Davidson MH, Dillon MA, Gordon B, Jones P, Samuels J, Weiss S, Isaacsohn J, Toth P, Burke SK.

Arch Intern Med. 1999 Sep 13;159(16):1893-900.

PMID:
10493319
5.

Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.

Bays H, Rhyne J, Abby S, Lai YL, Jones M.

Curr Med Res Opin. 2006 Nov;22(11):2191-200.

PMID:
17076980
6.

Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia.

Kerzner B, Corbelli J, Sharp S, Lipka LJ, Melani L, LeBeaut A, Suresh R, Mukhopadhyay P, Veltri EP; Ezetimibe Study Group.

Am J Cardiol. 2003 Feb 15;91(4):418-24.

PMID:
12586255
7.

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.

Huijgen R, Abbink EJ, Bruckert E, Stalenhoef AF, Imholz BP, Durrington PN, Trip MD, Eriksson M, Visseren FL, Schaefer JR, Kastelein JJ; Triple Study Group.

Clin Ther. 2010 Apr;32(4):615-25. doi: 10.1016/j.clinthera.2010.04.014.

PMID:
20435231
8.

Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study.

Knopp RH, Tsunehara C, Retzlaff BM, Fish B, Nguyen H, Anderson S, Nguyen T.

Metabolism. 2006 Dec;55(12):1697-703.

PMID:
17142146
9.

Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial.

Insull W Jr, Toth P, Mullican W, Hunninghake D, Burke S, Donovan JM, Davidson MH.

Mayo Clin Proc. 2001 Oct;76(10):971-82.

PMID:
11605698
10.

Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.

Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.

Clin Ther. 2008 Jan;30(1):84-97. doi: 10.1016/j.linthera.2008.01.013.

PMID:
18343245
11.

Colesevelam hydrochloride: a novel bile acid-binding resin.

Aldridge MA, Ito MK.

Ann Pharmacother. 2001 Jul-Aug;35(7-8):898-907. Review.

PMID:
11485143
13.
15.

Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively.

Hunninghake D, Insull W Jr, Toth P, Davidson D, Donovan JM, Burke SK.

Atherosclerosis. 2001 Oct;158(2):407-16.

PMID:
11583720
16.

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.

Goldberg RB, Fonseca VA, Truitt KE, Jones MR.

Arch Intern Med. 2008 Jul 28;168(14):1531-40. doi: 10.1001/archinte.168.14.1531.

PMID:
18663165
17.

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.

Bays HE, Goldberg RB, Truitt KE, Jones MR.

Arch Intern Med. 2008 Oct 13;168(18):1975-83. doi: 10.1001/archinte.168.18.1975.

PMID:
18852398
18.

Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol.

Bays HE, McKenney JM, Dujovne CA, Schrott HG, Zema MJ, Nyberg J, MacDougall DE; Gemcabene Study Group.

Am J Cardiol. 2003 Sep 1;92(5):538-43.

PMID:
12943873
19.

Colesevelam: in pediatric patients with heterozygous familial hypercholesterolemia.

Perry CM.

Paediatr Drugs. 2010 Apr 1;12(2):133-40. doi: 10.2165/11204890-000000000-00000. Review.

PMID:
20218749
20.

Colesevelam: a review of its use in hypercholesterolemia.

Robinson DM, Keating GM.

Am J Cardiovasc Drugs. 2007;7(6):453-65. Review.

PMID:
18076213
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk